https://www.selleckchem.com/pr....oducts/sitravatinib-
, having a good consistency with AMH and AFC. More importantly, inhibin B had an advantage in predicting AFC less then 5-7 compared with FSH, which suggested the potential of inhibin B in predicting ovarian response. These results will be helpful to the clinical application of inhibin B in the evaluation of female ovarian reserve and the assessment of their reproductive capacity. Trial registration http//clinicaltrials.gov; NCT02294500. Osteogenesis imperfecta (OI) type V is a rare form of OI which is often characterized by
Like
Comment
Share
